Related Experiment Video
Updated: Apr 26, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.3K
Minimally invasive compared with conventional thyroidectomy for nodular goitre.
Henning Dralle1, Andreas Machens1, Phuong Nguyen Thanh1
1Department of General, Visceral and Vascular Surgery, University Hospital, Medical Faculty, University of Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Halle/Saale, Germany.
Summary
Conventional open thyroidectomy remains the gold standard for nodular goiter. While minimally invasive thyroidectomy offers cosmetic benefits and less pain, it
Area of Science:
- Endocrine Surgery
- Surgical Oncology
Background:
- Minimally invasive thyroidectomy (MIT) approaches emerged in 1997.
- Various MIT techniques include minimal neck incision and extracervical access (chest, axillary).
- Conventional open thyroidectomy (COT) is versatile for all thyroid conditions.
Purpose of the Study:
- To compare the efficacy and safety of different thyroidectomy approaches.
- To evaluate cosmesis, postoperative pain, and surgical morbidity.
- To determine the gold standard for nodular goiter treatment.
Main Methods:
- Systematic review of 11 prospective randomized studies and 6 systematic reviews.
- Comparison of minimally invasive video-assisted thyroidectomy (MIVAT) with COT.
- Analysis of extracervical scarless neck thyroidectomy (ESNT) versus COT and MIT.
Main Results:
- MIVAT showed better short-term cosmesis and reduced pain compared to COT.
- Surgical morbidity was comparable between MIVAT and COT in limited studies.
- ESNT was associated with increased pain and unique complications compared to MIT and COT.
Conclusions:
- COT remains the gold standard for nodular goiter due to its broad applicability.
- MIVAT offers cosmetic advantages and reduced pain for select cases.
- ESNT presents significant drawbacks and lacks comparative evidence against COT.
Related Concept Videos
Goiter
27
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
27
The Thyroid Gland
6.9K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.9K
Hyperthyroidism II: Pathophysiology
25
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
25
Hyperthyroidism I: Introduction
25
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
25

